Desiccation

It’s hard to find fossil skin, but a rare discovery reveals clues about the evolution from water to land

Retrieved on: 
星期二, 五月 28, 2024

Fossilized skin and other soft tissues are exceedingly rare, and it is only under special conditions that these rarest of fossils are preserved.

Key Points: 
  • Fossilized skin and other soft tissues are exceedingly rare, and it is only under special conditions that these rarest of fossils are preserved.
  • Most skin is preserved as impressions in the rock, but under rare conditions and incalculable odds, a 3D fossil of the actual skin can form.

Fossilized skin

  • The fossilized skin is so well preserved that its internal structures can be identified and is the oldest such fossil currently known.
  • These early amniotes saw many evolutionary innovations that allowed them to adapt to the challenges of a fully terrestrial lifestyle, including several modifications to the epidermis, the outermost layer of skin.

Skin for living on land

  • One of the biggest hurdles to living on land is water retention.
  • The first tetrapods to lead largely terrestrial lives were amphibians whose skin was prone to drying out.
  • As such, they remained bound to an aquatic environment and lived a semi-aquatic lifestyle for at least part of their lives.
  • It was not until the evolution of reptiles, with their skin especially suited for water retention, that these pioneers were able to adopt fully terrestrial lifestyles.

A perfect cave system

  • These exceptional fossils were discovered in a cave system near Richards Spur, Oklahoma.
  • This cave system consists of expansive karst networks, which often appear as vertical fissures carved into surrounding limestone by water.
  • Cave conditions are known to promote preservation of animal remains through desiccation, permeation by mineral rich ground water and burial by fine sediments.

Peter Eckes, Former CTO of BASF Agricultural Solutions, to Chair Harpe Bioherbicide Board

Retrieved on: 
星期三, 四月 17, 2024

RESEARCH TRIANGLE PARK, N.C., April 17, 2024 /PRNewswire/ -- Harpe Bioherbicide Solutions, Inc., an agricultural technology company focused on providing natural and sustainable herbicide solutions, announced today that Dr. Peter Eckes, former President of BASF leading Crop Protection R&D, Seed and Trait R&D and Regulatory in the Agricultural Solutions division, has joined its board and will serve as board chairperson.

Key Points: 
  • "Harpe has both a compelling value proposition and strong business plan to bring new and natural weed control innovations to life," said Eckes.
  • Eckes assumes board leadership from Aidan J. Connolly, President of AgriTech Capital, who will remain as a Harpe Bioherbicide board member.
  • Additional Harpe Bioherbicide board members include CEO Buckner; Kip Tom, CEO of Tom Farms and former UN Ambassador; Robb Fraley, former CTO for Monsanto Co.; Chad Brommer, Harpe Bioherbicide co-founder and CTO; and Daniel Pepitone, Harpe Bioherbicide co-founder and COO.
  • Those attending are invited to visit Booth #22 to learn more about Harpe Bioherbicide formulations.

Peter Eckes, Former CTO of BASF Agricultural Solutions, to Chair Harpe Bioherbicide Board

Retrieved on: 
星期三, 四月 17, 2024

RESEARCH TRIANGLE PARK, N.C., April 17, 2024 /PRNewswire/ -- Harpe Bioherbicide Solutions, Inc., an agricultural technology company focused on providing natural and sustainable herbicide solutions, announced today that Dr. Peter Eckes, former President of BASF leading Crop Protection R&D, Seed and Trait R&D and Regulatory in the Agricultural Solutions division, has joined its board and will serve as board chairperson.

Key Points: 
  • "Harpe has both a compelling value proposition and strong business plan to bring new and natural weed control innovations to life," said Eckes.
  • Eckes assumes board leadership from Aidan J. Connolly, President of AgriTech Capital, who will remain as a Harpe Bioherbicide board member.
  • Additional Harpe Bioherbicide board members include CEO Buckner; Kip Tom, CEO of Tom Farms and former UN Ambassador; Robb Fraley, former CTO for Monsanto Co.; Chad Brommer, Harpe Bioherbicide co-founder and CTO; and Daniel Pepitone, Harpe Bioherbicide co-founder and COO.
  • Those attending are invited to visit Booth #22 to learn more about Harpe Bioherbicide formulations.

New, Natural Weed Control Effective Against Most Challenging Herbicide Resistant Weeds

Retrieved on: 
星期二, 三月 12, 2024

RESEARCH TRIANGLE PARK, N.C., March 12, 2024 /PRNewswire/ -- More than 1,000 global field and green house trials show Harpe Bioherbicide Solutions, Inc., plant extract-based herbicides provide effective control against a broad spectrum of broadleaf and grass weeds and seeds including the most challenging resistant weeds farmers face.

Key Points: 
  • The innovation comes as consumers are demanding more natural approaches to food production and farmers are having more difficulty managing yield-robbing weeds.
  • "Fewer, less effective weed control options mean reduced yields, increased costs and more pressure on farmer viability."
  • Since 1984, herbicide resistant weeds have increased by more than 600% globally and require farmers to increase spending and apply more herbicides than ever before to achieve some level of control.
  • Contact Daniel Pepitone at [email protected] to discuss Harpe Bio's role in the future of natural weed control solutions.

Dryad’s Silvanet Detects Unauthorized Wildfire in Lebanon in 30 Minutes, Prompting Timely Response and Resolution

Retrieved on: 
星期一, 十二月 18, 2023

With 139,000 hectares of forest, equivalent to roughly 13% of its land area, Lebanon’s forests are increasingly at risk.

Key Points: 
  • With 139,000 hectares of forest, equivalent to roughly 13% of its land area, Lebanon’s forests are increasingly at risk.
  • Extended periods of drought pose a threat, elevating the risk of fires in higher-altitude regions that historically experienced fewer wildfires.
  • Silvanet demonstrated its effectiveness by successfully detecting and alerting an unauthorized fire at 10:33 am on Monday 11th December.
  • This proactive response prevented the escalation of an illegal fire under challenging conditions, showcasing the reliability of Silvanet in real-world scenarios.

CTEK Shares How To Avoid Battery Drain In Record Heat

Retrieved on: 
星期五, 八月 4, 2023

CHICAGO, Aug. 4, 2023 /PRNewswire/ -- June and July saw record heat worldwide according to the World Meteorological Organization, and August is trending to be just as hot. As the summer heat intensifies, it's not just our bodies that need extra care and attention; our vehicle batteries also require special consideration to ensure optimal performance and reliability. With scorching temperatures and extended road trips on the horizon, it's important to understand the unique charging needs of your vehicle battery in the extreme heat.

Key Points: 
  • Heat increases the rate of chemical reactions inside the battery, causing the electrolyte to evaporate more quickly and accelerating internal corrosion.
  • In the winter, the battery needs to work harder and you won't be able to start with a discharged battery.
  • That's why many of you proactively charge and maintain your vehicle battery during the winter, to avoid breakdowns and a discharged battery.
  • Understand how heat affects your battery: As temperatures outside heat up, so does the temperature under the hood of your car, truck, or SUV.

Bausch + Lomb and Novaliq Announce FDA Approval of MIEBO™ (Perfluorohexyloctane Ophthalmic Solution) for the Treatment of the Signs and Symptoms of Dry Eye Disease

Retrieved on: 
星期四, 五月 18, 2023

MIEBO is the first and only FDA-approved treatment for DED that directly targets tear evaporation.

Key Points: 
  • MIEBO is the first and only FDA-approved treatment for DED that directly targets tear evaporation.
  • “Today’s FDA approval of MIEBO further advances DED treatment by addressing a significant unmet need for millions of people suffering with this disease,” said Brent Saunders, chairman and CEO, Bausch + Lomb.
  • “We are proud to bring to market the first and only prescription eye drop approved in the United States for the treatment of DED that directly targets evaporation.
  • “We are grateful to Bausch + Lomb for their continued collaboration in bringing this unique new treatment option to market.”
    MIEBO™ (perfluorohexyloctane ophthalmic solution) is used to treat the signs and symptoms of dry eye disease.

Harpe Bioherbicide Solutions, Inc. Closes New Investment Round, Including ADM

Retrieved on: 
星期二, 四月 18, 2023

RESEARCH TRIANGLE PARK, N.C., April 18, 2023 /PRNewswire/ -- Harpe Bioherbicide Solutions, Inc., an agricultural technology company focused on providing natural and sustainable herbicide solutions, today announced a $10.5 million round of fundraising, led by ADM (NYSE: ADM). Follow-on investments in the oversubscribed round included iSelect Fund Management and Alexandria Investment Ventures as well as company leadership and private agricultural industry investors.

Key Points: 
  • RESEARCH TRIANGLE PARK, N.C., April 18, 2023 /PRNewswire/ -- Harpe Bioherbicide Solutions, Inc., an agricultural technology company focused on providing natural and sustainable herbicide solutions, today announced a $10.5 million round of fundraising, led by ADM (NYSE: ADM).
  • Follow-on investments in the oversubscribed round included iSelect Fund Management and Alexandria Investment Ventures as well as company leadership and private agricultural industry investors.
  • In addition, the financing supports the next development stages of Harpe herbicide-tolerant row crop systems, which will further expand and strengthen Harpe's intellectual property portfolio.
  • "Harpe Bioherbicide Solutions exists to serve farmers on a global scale by developing novel and natural herbicide solutions to help mitigate increasing weed resistance challenges while seeking to advance sustainable practices in global food production," said Daniel Pepitone, COO of Harpe Bioherbicide Solutions.

Harpe Bioherbicide Solutions, Inc. Closes New Investment Round, Including ADM

Retrieved on: 
星期二, 四月 18, 2023

RESEARCH TRIANGLE PARK, N.C., April 18, 2023 /PRNewswire/ -- Harpe Bioherbicide Solutions, Inc., an agricultural technology company focused on providing natural and sustainable herbicide solutions, today announced a $10.5 million round of fundraising, led by ADM (NYSE: ADM). Follow-on investments in the oversubscribed round included iSelect Fund Management and Alexandria Investment Ventures as well as company leadership and private agricultural industry investors.

Key Points: 
  • RESEARCH TRIANGLE PARK, N.C., April 18, 2023 /PRNewswire/ -- Harpe Bioherbicide Solutions, Inc., an agricultural technology company focused on providing natural and sustainable herbicide solutions, today announced a $10.5 million round of fundraising, led by ADM (NYSE: ADM).
  • Follow-on investments in the oversubscribed round included iSelect Fund Management and Alexandria Investment Ventures as well as company leadership and private agricultural industry investors.
  • In addition, the financing supports the next development stages of Harpe herbicide-tolerant row crop systems, which will further expand and strengthen Harpe's intellectual property portfolio.
  • "Harpe Bioherbicide Solutions exists to serve farmers on a global scale by developing novel and natural herbicide solutions to help mitigate increasing weed resistance challenges while seeking to advance sustainable practices in global food production," said Daniel Pepitone, COO of Harpe Bioherbicide Solutions.

RedDress Announces Positive Results Specifying Use on Complex Wounds

Retrieved on: 
星期五, 一月 20, 2023

Jacksonville, Fla, Jan. 20, 2023 (GLOBE NEWSWIRE) -- RedDress, a privately held U.S. and Israel-based medical device company, today announced that new data has been published outlining their wound care product, ActiGraft+ , use on complex wounds.

Key Points: 
  • Jacksonville, Fla, Jan. 20, 2023 (GLOBE NEWSWIRE) -- RedDress, a privately held U.S. and Israel-based medical device company, today announced that new data has been published outlining their wound care product, ActiGraft+ , use on complex wounds.
  • “Clinical data is foundational to validating our technology and progressing how clinicians manage wounds to improve their patient’s outcomes,” said Sharon Sirota, Clinical Team Leader at RedDress.
  • TABCT should be applied to wounds after adequate debridement in patients in which this can be performed.
  • These statements as well as previously published clinical data highlight that using autologous therapies on complex, hard-to-heal wounds is an effective and viable solution for the patient,” said Dr. Robert Snyder, one of RedDress’ medical advisors.